Cargando…

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection

Detalles Bibliográficos
Autor principal:	Kim, Tae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338243/ https://www.ncbi.nlm.nih.gov/pubmed/37424498 http://dx.doi.org/10.3904/kjim.2023.250

Ejemplares similares

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
por: Yamada, Shinya, et al.
Publicado: (2016)

Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?
por: Sue, Soichiro, et al.
Publicado: (2021)

Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line Helicobacter Pylori Eradication Therapy Administered with Bismuth
por: Kim, Ji Yeon, et al.
Publicado: (2021)

Role of Tegoprazan in Helicobacter pylori Eradication Therapy
por: Lee, Jin
Publicado: (2022)

Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials
por: Zhang, Mengran, et al.
Publicado: (2022)

Helicobacter pylori Eradication, a Gordian Knot for Idiopathic Thrombocytopenic Purpura?
por: Kim, Tae Ho, et al.
Publicado: (2016)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

The role of acid inhibition in Helicobacter pylori eradication
por: Scott, David R., et al.
Publicado: (2016)

Strategies for Helicobacter pylori eradication in the year 2020
por: Pellicano, Rinaldo, et al.
Publicado: (2020)

Probiotics as Dietary Supplements for Eradication of Helicobacter pylori Infection in Children: A Role Beyond Infection
por: Hassan, Sherif T. S., et al.
Publicado: (2016)

Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
por: Masaoka, Tatsuhiro, et al.
Publicado: (2018)

Time to learn from the past and prepare for the future in Helicobacter pylori eradication
por: Bang, Chang Seok, et al.
Publicado: (2015)

Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
por: Murakami, Kazunari, et al.
Publicado: (2016)

Changes in Metabolic Parameters by Helicobacter pylori Eradication According to Sex Differences
por: Kim, Sung Eun
Publicado: (2023)

Can Helicobacter pylori eradication affect long-term mortality?
por: Lee, Hang Lak
Publicado: (2021)

Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?
por: Hunt, Richard H, et al.
Publicado: (2015)

Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Düzenli, Tolga, et al.
Publicado: (2023)

Personalized Approach in Eradication of Helicobacter pylori Infection
por: Mestrovic, Antonio, et al.
Publicado: (2022)

Pharmacoeconomics - Determiniation of the Cost-Effectiveness of Helicobacter Pylori Eradication
por: Curtiss, Frederic R.
Publicado: (2003)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
por: Choi, Yoon Jin, et al.
Publicado: (2022)

Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022)

Effect of Helicobacter pylori Eradication on Functional Dyspepsia
por: Kim, Sung Eun, et al.
Publicado: (2013)

Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?
por: Jeon, Hye Kyung, et al.
Publicado: (2014)

The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication
por: Choe, Younghee, et al.
Publicado: (2022)

There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding
por: Lee, Sun-Young
Publicado: (2015)

Exploring the Link between Helicobacter pylori Eradication and Metachronous Gastric Cancer Development
por: Yang, Hyo-Joon
Publicado: (2018)

Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection
por: Yang, Jyh-Chin, et al.
Publicado: (2013)

Efficacy of Two Triple Eradication Regimens in Children with Helicobacter pylori Infection
por: Choi, Jungi, et al.
Publicado: (2006)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
por: Sugimoto, Mitsushige, et al.
Publicado: (2019)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Therapeutic eradication choices in Helicobacter pylori infection in children
por: Manfredi, Marco, et al.
Publicado: (2023)

RE: Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection
por: Bang, Chang Seok, et al.
Publicado: (2015)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

Helicobacter pylori eradication in the management of glaucoma
por: Ala, Shahram, et al.
Publicado: (2020)

Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019)

Protonated Form: The Potent Form of Potassium-Competitive Acid Blockers
por: Luo, Hua-Jun, et al.
Publicado: (2014)

The Effect of Food on the Pharmacokinetics of the Potassium‐Competitive Acid Blocker Vonoprazan
por: Mulford, Darcy J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6vj5t24g1ngde5q2nb6o8abrh1